GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bloomage Biotechnology Corp 688363.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

34.56

-0.58%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

12 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 5Buy
  • 2Hold
  • 2Sell
  • 1Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 34.56Average target 47.30

Low
30.30
Average
47.30
Median
53.24
High
68.25

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥3.71bnCN¥4.04bnCN¥4.27bn
Revenue, highestCN¥3.96bnCN¥4.40bnCN¥4.61bn
Revenue, lowestCN¥3.55bnCN¥3.76bnCN¥4.03bn
Earnings per share0.690.941.12
Earnings per share, highest0.761.041.34
Earnings per share, lowest0.640.870.89
Analysts665

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.130.240.270.230.260.530.640.28
Reported0.070.180.130.080.070.250.21-0.39
Difference-45.3%-25.5%-51.9%-64.4%-75.1%-52.4%-67.0%-238.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 20.5% a year over 10 years. Return on equity 4.1%.

Model fair value

71.75

From earnings 71.75, from revenue 42.69.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.